Sinovac Reports Unaudited Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Sinovac Biotech (SVA) Tops Q2 EPS by 5c
August 12, 2015 4:32 PM EDTSinovac Biotech (NASDAQ: SVA) reported Q2 EPS of $0.04, $0.05 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $15.7 million.
For earnings history and earnings-related data on Sinovac Biotech (SVA) click here.
... More